AB Science SA (Over The Counter Market:ABSCF)
| 11.90 Delayed Data As of Apr 25 |  0.00 / 0.00%Today’s Change | 8.65 Today|||52-Week Range 18.78 | -- Year-to-Date |
| SECTOR Health Technology | INDUSTRY Pharmaceuticals: Other | MARKET CAP $632.7M |
Company Description
AB Science SA operates as a pharmaceutical company. The firm specializes in the research, development and commercialization of protein kinase inhibitors (PKIs), a class of targeted proteins whose action are key in signaling pathways within cells. Its pipeline includes Masitinib and AB8939. The company was founded by Alain Moussy and Jean-Pierre Kinet on July 11, 2001 and is headquartered in Paris, France.
Contact Information
AB Science SA 3, avenue George V Paris Ile-de-france 75008 |
Employees
Shareholders
| Mutual fund holders | -- |
| Individual stakeholders | -- |
| Other institutional | -- |
Top Executives
| Alain Moussy | Chairman & Chief Executive Officer |
| Laurent Guy | Chief Financial Officer |
| Christian Fassotte | Global Chief Medical Officer |
| Véronique Gélébart | Head-Clinical Operations & Clinical Development |
